Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus

Area of Science:

• Rheumatology
• Cardiology
• Immunology

Background:

• Cardiovascular diseases (CVD) are a primary cause of mortality in systemic lupus erythematosus (SLE) patients.
• Traditional risk scores inadequately assess CVD risk in SLE, necessitating novel biomarkers.
• Inflammation is recognized as a key driver of atherosclerosis development in SLE.

Purpose of the Study:

• To identify novel proinflammatory and pro-atherosclerotic risk factors in SLE.
• To improve cardiovascular risk stratification in SLE patients.
• To understand mechanisms linking SLE inflammation to early cardiovascular events.

Main Methods:

• Review of existing literature on SLE, inflammation, and atherosclerosis.
• Analysis of proposed novel biomarkers related to SLE pathogenesis.
• Correlation of identified risk factors with subclinical CVD and early cardiovascular events.

Main Results:

• Novel inflammatory and pro-atherosclerotic factors are closely associated with SLE.
• These factors contribute to an increased risk of early cardiovascular events in SLE patients.
• Current risk scores underestimate CVD risk in this population.

Conclusions:

• Identifying novel biomarkers is crucial for accurate CVD risk stratification in SLE patients.
• Targeting inflammation may mitigate cardiovascular risk in SLE.
• Further research is needed to validate these novel risk factors.